Peer-reviewed paper on “Unraveling the impaired incretin effect in obesity and type 2 diabetes: Key role of hyperglycemia-induced unscheduled glycolysis and glycolytic overload”

2024 Paper on how GlucoRegulate may be an adjunct/standalone for incretin therapeutics